as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹27.71
Change
+0.3 (1.09%)
Open
₹27.41
Prev. Close
₹27.41
Day High
₹27.78
Day Low
₹27.35
Volume Analysis
Traded
429,897
Delivered
303,956
Delivery %
70.7%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹28.3 | ₹28.04 | ₹27.87 | ₹27.61 | ₹27.44 | ₹27.18 | ₹27.01 |
| Fibonacci | ₹28.04 | ₹27.88 | ₹27.77 | ₹27.61 | ₹27.45 | ₹27.34 | ₹27.18 |
| Camarilla | ₹27.83 | ₹27.79 | ₹27.75 | ₹27.61 | ₹27.67 | ₹27.63 | ₹27.59 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-0.82%
1 Week
+0.11%
1 Month
+9.27%
3 Months
-1.28%
6 Months
+4.06%
1 Year
-0.79%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc - Icicialplv lands in the middle of the pack on TopFund's composite fundamentals check, at 62/100. The strongest factor is Risk & Volatility (70/100), while Liquidity (52/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
62/100 — AverageData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Icicialplv?
Frequently Asked Questions about Icicipramc - Icicialplv
Icicipramc - Icicialplv (ALPL30IETF) closed at ₹27.71 on NSE on 19 November 2026, up 0.3 (1.09%) from the previous close.
Icicipramc - Icicialplv trades on the NSE (National Stock Exchange of India) under the symbol ALPL30IETF.
Icicipramc - Icicialplv has a TopFund Quality Score of 62/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Icicialplv?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.